When is it right to reject an expensive new drug?
Articles on Alzheimer's disease
Displaying 61 - 80 of 448 articles
Helicobacter pylori, best known for causing stomach ulcers, was shown to block the build-up of both amyloid-beta and tau in our study.
Rosemary isn’t just for roast potatoes. It may also support memory, protect brain cells and help fight inflammation — even showing promise in Alzheimer’s research.
Even small lifestyle changes – such as more social interaction and a better diet – can help reduce stress.
Donanemab is only for use in the early stages of Alzheimer’s disease. And for now at least, it comes with a hefty price tag.
Alzheimer’s researcher Donald Weaver tells The Conversation Weekly podcast what he’s learnt during more than 30 years of studying the disease.
Alzheimer’s is a complex disease caused by many interacting factors. It’s possible the herpes virus could play a small role – but the evidence isn’t conclusive.
Dementia patient Auguste Deter’s contribution to the 1907 single case report study by Alois Alzheimer was immense: Deter’s life, illness and death are the story of Alzeimer’s disease.
A US study shows that many research participants don’t want to know their risks of getting Alzheimer’s disease.
Perseverance helps people achieve goals and is linked with well-being. But combined with chronic societal stressors, it can lead to cognitive overload that puts a strain on brain health.
However, our study also revealed that in female mice, certain prescription drug combos actually sped up the progression of Alzheimer’s disease.
Menopause is more than a life transition; it may also offer critical insights into long-term brain health.
It has taken decades for our theory that Alzheimer’s is triggered by viral infections to be taken seriously.
The scientist who discovered Alzheimer’s disease died in a Nazi transit camp and was almost forgotten by history.
Large study questions marriage’s protective effect on brain health. But the picture is complex.
Around 5-10% of all Alzheimer’s cases are in people under the age of 65.
Spotting Alzheimer’s disease early can help find the right treatments and support.
Rather than seeking a single cure — a magic bullet — for Alzheimer’s disease, a shotgun blast of different drugs with different targets may be a better approach to this very complex condition.
The majority of the 23 states disproportionately affected by the cuts are red states.
Fine-tuning our oral microbiomes might be the key to fighting dementia.
Top contributors
-
PhD Candidate, Neuroscience, University of Sheffield
-
Research Fellow in Neuroimmunology, UCL
-
Professor of Biological Psychology, Loughborough University
-
Professor of Chemistry and Senior Scientist of the Krembil Research Institute, University Health Network, University of Toronto
-
Head of Clinical Services, Dementia Support Australia, & Associate Professor of Psychiatry, Monash University
-
Professor Emeritus of Molecular Neurobiology at the University of Manchester and a Visiting Professorial Fellow, University of Oxford
-
Associate Professor, Turner Institute for Brain and Mental Health, Monash University
-
Professor of Neurology and Neuroscience, University of Florida
-
Host, The Conversation Weekly Podcast, The Conversation
-
Professor of Neurology, UCL
-
Post grad student at University of Edinburgh, University of Edinburgh
-
Associate Professor in Cellular Neuroscience, University of Reading
-
Professor of Psychology in Epidemiology, UCL
-
Étudiant au doctorat en psychologie, Université du Québec à Montréal (UQAM)
-
Affiliate Professor, Department of Family Medicine, McGill University